Lisa Lancaster

January 15, 2015

New drugs approved to fight idiopathic pulmonary fibrosis

The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).

By Kathy Whitney
man wearing cpap
April 13, 2012

Study examines sleep apnea’s role in lung diseases

Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases.

By Kathy Whitney
X-ray of lungs
October 31, 2011

Lung disorder drug regimen found harmful

Longtime treatment for IPF ineffective and even dangerous.

By Kathy Whitney